Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Altris AI is a Decision Making Support for OCT that detects, quantifies, and tracks 70 + retina pathologies on OCT scans, including early glaucoma. The system is FDA-cleared (510K), CE-certified,…

Altris AI is a Decision Making Support for OCT that detects, quantifies, and tracks 70 + retina pathologies on OCT scans, including early glaucoma. The system is FDA-cleared (510K), CE-certified,…
Product: FDA-cleared, CE-certified AI decision-support platform for OCT that detects 70+ retinal pathologies
Regulatory: FDA 510(k) clearance and Health Canada approval
Customers: Used by 500+ eye care specialists
Founding: Founded from a research collaboration in 2017; company incorporated in April 2018
Ophthalmic diagnostics — improving detection, quantification, and longitudinal tracking of retinal pathologies from OCT scans.
2018
MedTech / Healthcare (Ophthalmology)
80.75 MSEK
Funding round reported by Dealroom
“University of Chicago identified as first investor; Crunchbase lists multiple investors including Network.VC and Digital Future”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,500+
New This Week
| Company |
|---|